From: Potential drug incompatibilities in the neonatal intensive care unit: a network analysis approach
Medicine pairs | Number | Percent | Days of prescriptions | Interaction characteristics | |
---|---|---|---|---|---|
Median | Range | ||||
Ampicillin – Gentamicin | 158 | 14.2 | 6 | 1–13 | A |
Aminophylline – Ampicillin | 77 | 6.91 | 5 | 1–11 | E |
Ampicillin – Fentanyl | 61 | 5.48 | 5 | 1–11 | A |
Cefepime – Fentanyl | 35 | 3.14 | 5 | 1–11 | B |
Aminophylline – Cefepime | 32 | 2.87 | 5 | 1–10 | B |
Aminophylline – Dobutamine | 28 | 2.51 | 3 | 1–18 | D |
Ampicillin – Dobutamine | 26 | 2.33 | 3 | 1–10 | C |
Furosemide – Gentamicin | 26 | 2.33 | 2 | 1–10 | A |
Fentanyl – Meropenem | 25 | 2.24 | 9 | 2–18 | B |
Dobutamine – Furosemide | 23 | 2.06 | 4 | 1–48 | A |
Total | 1114 | 100.00 | 8 | 1–48 | – |